Stemline Therapeutics, Inc. (STML) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Stemline Therapeutics, Inc. (STML) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Stemline Therapeutics, Inc. (STML) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Stemline Therapeutics, Inc. (STML) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
27 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Stemline Therapeutics, Inc. (Stemline) is a clinical stage biopharmaceutical company that develops therapeutics to treat cancer stem cells and tumor bulk. The company has developed discovery platform StemScreen, a to identify novel compounds that target and kill cancer stem cells. Its products pipeline includes SL-401, SL-701, SL-801, SL-501 and SL-101. Stemline's SL-401 is a targeted therapy directed to the interleukin-3 receptor (IL-3R) present on CSCs and tumor bulk of hematologic cancers. The company's SL-701 is an immunotherapy designed to activate the immune system to attack tumors. Its SL-801 is a novel oral small molecule reversible inhibitor of Exportin-1.

Stemline Therapeutics, Inc. (STML) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have s

  
Source:
Document ID
GDPH137219D
Country
Industry
Ticker
STML=US
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Stemline Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Stemline Therapeutics, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Stemline Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Stemline Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Stemline Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201691
Stemline Therapeutics, Inc., Pharmaceuticals &Healthcare, Deal Details1014
  Venture Financing101
    Stemline Therapeutics Raises US$0.74 Million In Venture Financing101
  Partnerships111
    Stemline Therapeutics Enters Into Co-Development Agreement With Leukemia &Lymphoma Society112
  Licensing Agreements131
    Stemline Therapeutics Enters into Licensing Agreement with CanBas131
    Stemline Therapeutics Enters into Licensing Agreement with CanBas for CBS-9106141
    Stemline Therapeutics Enters Into Licensing Agreement With University of Pittsburgh For EphA2151
    Stemline Therapeutics Enters Into Licensing Agreement With University of Pittsburgh For SL-701161
    Stemline Therapeutics Enters Into Licensing Agreement With University Of Pittsburgh171
  Equity Offering181
    Stemline Therapeutics Prices Public Offering of Shares for USD60 Million182
    Stemline Therapeutics Announces Full Exercise Of Underwriter's Option For Public Offering Of Shares For US$69 Million202
    Stemline Therapeutics Completes IPO For US$38.15 Million222
Stemline Therapeutics, Inc. - Key Competitors241
Key Employees251
Locations And Subsidiaries261
  Head Office261
Appendix271
  Methodology271
  About GlobalData271
  Contact Us271
  Disclaimer271

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Stemline Therapeutics, Inc. (STML) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Stemline-Therapeutics-Inc-STML-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7800>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Stemline Therapeutics, Inc. (STML) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Stemline-Therapeutics-Inc-STML-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7800>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research